-DOCSTART- -5410150- O O

The DT N
need NN N
for IN N
chemotherapy NN i
after IN N
prolonged JJ p
complete JJ p
remission NN p
in IN p
acute JJ p
leukemia NN p
of IN p
childhood NN p
. . p

-DOCSTART- -20562617- O O

Hematologic NNP p
patients NNS p
' POS p
clinical JJ p
and CC p
psychosocial JJ p
experiences NNS p
with IN p
implanted JJ i
long-term JJ i
central JJ i
venous JJ i
catheter NN i
: : i
self-management JJ N
versus NN N
professionally RB N
controlled VBN N
care NN N
. . N

BACKGROUND VB N
A DT N
significant JJ N
decrease NN N
in IN N
catheter-related JJ N
infections NNS N
was VBD N
demonstrated VBN N
in IN N
our PRP$ N
earlier JJR N
randomized VBN N
controlled JJ N
trial NN N
of IN N
central JJ N
venous JJ N
catheter NN N
( ( N
CVC NNP N
) ) N
care NN N
in IN N
hematologic JJ p
patients NNS p
. . p

OBJECTIVE IN N
This DT N
article NN N
focuses VBZ N
on IN N
patients NNS N
' POS N
clinical JJ N
and CC N
psychosocial JJ N
experiences NNS N
with IN N
CVC NNP i
self-care NN i
compared VBN N
with IN N
professionally RB i
controlled VBN i
CVC NNP i
care NN i
. . i

METHODS NNP N
Eighty-two JJ p
patients NNS p
with IN p
tunneled JJ p
CVCs NNP p
were VBD N
enrolled VBN N
in IN N
the DT N
randomized NN N
controlled VBD N
trial NN N
. . N

The DT N
intervention NN N
group NN N
( ( N
n JJ N
= NNP N
42 CD N
) ) N
was VBD N
trained VBN N
to TO N
perform VB N
CVC NNP i
self-care NN i
. . i

The DT N
control NN N
group NN N
( ( N
n JJ N
= NNP N
40 CD N
) ) N
followed VBD N
standard JJ i
CVC NNP i
procedure NN i
provided VBN i
by IN i
nurses NNS i
. . i

Eighteen JJ N
patients NNS N
were VBD N
selected VBN N
for IN N
semistructured JJ N
interviews NNS N
focusing VBG N
on IN N
patients NNS N
' POS N
clinical JJ N
and CC N
psychosocial JJ N
experiences NNS N
with IN N
CVCs NNP N
. . N

RESULTS NNP N
Methods NNP N
of IN N
CVC NNP N
care NN N
have VBP N
different JJ N
influences NNS N
on IN N
the DT N
patients NNS N
' POS N
clinical JJ o
and CC o
psychosocial JJ o
outcomes NNS o
, , N
depending VBG N
on IN N
whether IN N
they PRP N
were VBD N
hospitalized VBN N
or CC N
outpatients NNS N
. . N

Central NNP i
venous JJ i
catheter NN i
was VBD N
viewed VBN N
as IN N
important JJ N
because IN N
it PRP N
was VBD N
the DT N
main JJ N
port NN N
of IN N
treatment NN N
toward IN N
a DT N
cure NN N
, , N
although IN N
patients NNS N
constantly RB N
fear VBP N
complications NNS N
. . N

Central NNP i
venous JJ i
catheter NN i
self-care NN i
increased VBD N
patients NNS o
' POS o
independence NN o
from IN N
health NN N
professionals NNS N
and CC N
supported VBD N
perceived VBN N
self-efficacy NN o
and CC N
control NN N
. . N

Central NNP N
venous JJ N
catheters NNS N
cause VBP N
psychosocial JJ o
problems NNS o
including VBG N
altered VBD o
body NN o
perception NN o
, , o
sexual JJ o
activity NN o
avoidance NN o
, , o
and CC o
feeling VBG o
stigmatized VBN o
. . o

CONCLUSIONS JJ N
Patients NNPS N
experience NN N
increased VBD N
perceived VBN o
self-control NN o
and CC o
independence NN o
when WRB N
individually RB N
supervised VBN N
and CC N
trained VBN N
in IN N
CVC NNP i
self-management NN i
. . i

Assuming VBG N
ownership NN N
of IN N
CVC NNP N
care NN N
can MD N
encourage VB N
patients NNS N
to TO N
feel VB N
less RB N
inhibited VBN N
about IN N
sexual JJ o
activity NN o
and CC o
socialization NN o
. . o

IMPLICATIONS NNP N
FOR NNP N
PRACTICE NNP N
Placement NNP N
of IN N
a DT N
tunneled JJ N
CVC NNP N
should MD N
engage VB N
nurses NNS N
to TO N
organize VB N
individualized JJ N
structured VBN N
and CC N
supervised VBN N
patient JJ N
education NN N
. . N

Stigma NNP N
originating VBG N
from IN N
CVCs NNP N
should MD N
be VB N
carefully RB N
considered VBN N
by IN N
health NN N
professionals NNS N
when WRB N
maintaining VBG N
CVC NNP N
insertion NN N
for IN N
longer JJR N
periods NNS N
. . N

Central NNP N
venous JJ N
catheters NNS N
should MD N
be VB N
removed VBN N
whenever WRB N
the DT N
potential JJ N
risks NNS N
exceed VBP N
the DT N
catheter NN N
's POS N
functional JJ N
necessity NN N
. . N

-DOCSTART- -15536093- O O

Syncope NNP p
Evaluation NNP N
in IN N
the DT N
Emergency NNP N
Department NNP N
Study NNP N
( ( N
SEEDS NNP N
) ) N
: : N
a DT N
multidisciplinary JJ N
approach NN N
to TO N
syncope VB p
management NN N
. . N

BACKGROUND VB N
The DT N
primary JJ N
aim NN N
and CC N
central JJ N
hypothesis NN N
of IN N
the DT N
study NN N
are VBP N
that IN N
a DT N
designated VBN N
syncope NN N
unit NN N
in IN N
the DT N
emergency NN N
department NN N
improves VBZ N
diagnostic JJ N
yield NN N
and CC N
reduces NNS N
hospital JJ N
admission NN N
for IN N
patients NNS p
with IN p
syncope NN p
who WP p
are VBP p
at IN p
intermediate JJ p
risk NN p
for IN p
an DT p
adverse JJ p
cardiovascular JJ p
outcome NN p
. . p

METHODS NNP N
AND CC N
RESULTS NNP N
In IN N
this DT N
prospective JJ N
, , N
randomized VBN N
, , N
single-center JJ p
study NN p
, , p
patients NNS p
were VBD N
randomly RB N
allocated VBN N
to TO N
2 CD N
treatment NN N
arms NNS N
: : N
syncope NN i
unit NN i
evaluation NN i
and CC i
standard NN i
care NN i
. . i

The DT N
2 CD N
groups NNS N
were VBD N
compared VBN N
with IN N
chi2 JJ N
test NN N
for IN N
independence NN N
of IN N
categorical JJ N
variables NNS N
. . N

Wilcoxon NNP N
rank VBD N
sum JJ N
test NN N
was VBD N
used VBN N
for IN N
continuous JJ N
variables NNS N
. . N

Survival NNP o
was VBD N
estimated VBN N
with IN N
the DT N
Kaplan-Meier NNP N
method NN N
. . N

One CD p
hundred VBD p
three CD p
consecutive JJ p
patients NNS p
( ( p
53 CD p
women NNS p
; : p
mean JJ p
age NN p
64+/-17 CD p
years NNS p
) ) p
entered VBD p
the DT p
study NN p
. . p

Fifty-one CD N
patients NNS N
were VBD N
randomized VBN N
to TO N
the DT N
syncope NN N
unit NN N
. . N

For IN N
the DT N
syncope NN N
unit NN N
and CC N
standard JJ N
care NN N
patients NNS N
, , N
the DT N
presumptive JJ o
diagnosis NN o
was VBD N
established VBN N
in IN N
34 CD N
( ( N
67 CD N
% NN N
) ) N
and CC N
5 CD N
( ( N
10 CD N
% NN N
) ) N
patients NNS N
( ( N
P NNP N
< NNP N
0.001 CD N
) ) N
, , N
respectively RB N
, , N
hospital JJ o
admission NN o
was VBD N
required VBN N
for IN N
22 CD N
( ( N
43 CD N
% NN N
) ) N
and CC N
51 CD N
( ( N
98 CD N
% NN N
) ) N
patients NNS N
( ( N
P NNP N
< NNP N
0.001 CD N
) ) N
, , N
and CC N
total JJ o
patient-hospital JJ o
days NNS o
were VBD N
reduced VBN N
from IN N
140 CD N
to TO N
64 CD N
. . N

Actuarial JJ o
survival NN o
was VBD N
97 CD N
% NN N
and CC N
90 CD N
% NN N
( ( N
P=0.30 NNP N
) ) N
, , N
and CC N
survival JJ o
free JJ o
from IN o
recurrent JJ o
syncope NN o
was VBD N
88 CD N
% NN N
and CC N
89 CD N
% NN N
( ( N
P=0.72 NNP N
) ) N
at IN N
2 CD N
years NNS N
for IN N
the DT N
syncope NN N
unit NN N
and CC N
standard JJ N
care NN N
groups NNS N
, , N
respectively RB N
. . N

CONCLUSIONS VB N
The DT N
novel JJ N
syncope NN N
unit NN N
designed VBN N
for IN N
this DT N
study NN N
significantly RB N
improved VBN N
diagnostic JJ o
yield NN o
in IN N
the DT N
emergency NN N
department NN N
and CC N
reduced JJ N
hospital NN o
admission NN o
and CC N
total JJ o
length NN o
of IN o
hospital NN o
stay NN o
without IN N
affecting VBG N
recurrent NN N
syncope NN N
and CC N
all-cause JJ N
mortality NN o
among IN N
intermediate-risk JJ p
patients NNS p
. . p

Observations NNS N
from IN N
the DT N
present JJ N
study NN N
provide VBP N
benchmark NN N
data NNS N
for IN N
improving VBG N
patient NN N
care NN N
and CC N
effectively RB N
utilizing JJ N
healthcare JJ N
resources NNS N
. . N

-DOCSTART- -15610252- O O

B-type JJ i
natriuretic JJ i
peptide NN i
for IN N
acute JJ N
dyspnea NN N
in IN N
patients NNS p
with IN p
kidney JJ p
disease NN p
: : p
insights NNS N
from IN N
a DT N
randomized JJ N
comparison NN N
. . N

BACKGROUND NNP N
B-type NNP o
natriuretic JJ o
peptide NN o
( ( o
BNP NNP o
) ) o
levels NNS o
are VBP N
reliably RB N
elevated VBN N
in IN N
patients NNS p
with IN p
congestive JJ p
heart NN p
failure NN p
( ( p
CHF NNP p
) ) p
and CC N
therefore RB N
helpful JJ N
in IN N
its PRP$ N
diagnosis NN N
. . N

However RB N
, , N
kidney FW N
disease NN N
results NNS N
in IN N
elevated JJ N
BNP NNP N
levels NNS N
independently RB N
of IN N
CHF NNP N
. . N

Accordingly RB N
, , N
the DT N
impact NN N
of IN N
kidney NN N
disease NN N
on IN N
the DT N
benefit NN N
of IN N
BNP NNP i
testing VBG N
needs NNS N
to TO N
be VB N
scrutinized VBN N
. . N

METHODS NNP N
This DT N
study NN N
evaluated VBD N
patients NNS p
with IN p
and CC p
without IN p
kidney NN p
disease NN p
[ NNP p
glomerular JJ p
filtration NN p
rate NN p
( ( p
GFR NNP p
) ) p
less JJR p
than IN p
60 CD p
mL/min/1.73 JJ p
m NN p
( ( p
2 CD p
) ) p
) ) p
presenting VBG p
with IN p
acute JJ p
dyspnea NN p
. . p

A DT N
total NN N
of IN N
452 CD p
consecutive JJ p
patients NNS p
( ( p
240 CD p
with IN p
kidney NN p
disease NN p
and CC p
212 CD p
without IN p
kidney NN p
disease NN p
) ) p
were VBD N
randomly RB N
assigned VBN N
to TO N
a DT N
diagnostic JJ i
strategy NN i
with IN i
( ( i
BNP NNP i
group NN i
) ) i
or CC i
without IN i
( ( i
control NN i
group NN i
) ) i
the DT i
use NN i
of IN i
BNP NNP i
levels NNS i
provided VBN i
by IN i
a DT i
rapid JJ i
bedside NN i
assay NN i
. . i

RESULTS JJ N
Patients NNS p
with IN p
kidney JJ p
disease NN p
were VBD p
older JJR p
, , p
more RBR p
often RB p
had VBD p
CHF NNP o
as IN o
the DT o
cause NN o
of IN o
acute JJ o
dyspnea NN o
, , p
and CC p
more RBR p
often RB p
died JJ p
in-hospital JJ p
or CC p
within IN p
30 CD p
days NNS p
as RB p
compared VBN p
to TO p
patients NNS p
without IN p
kidney NN p
disease NN p
. . N

In IN N
patients NNS N
without IN N
kidney NN N
disease NN N
, , N
BNP NNP i
testing VBG i
significantly RB N
reduced VBN N
median JJ o
time NN o
to TO o
discharge VB o
( ( N
from IN N
9.5 CD N
days NNS N
to TO N
2.5 CD N
days NNS N
) ) N
( ( N
P= NNP N
0.003 CD N
) ) N
and CC N
total JJ o
cost NN o
of IN o
treatment NN o
( ( N
from IN N
7184 CD N
dollars NNS N
to TO N
4151 CD N
dollars NNS N
) ) N
( ( N
P= NNP N
0.004 CD N
) ) N
. . N

In IN N
contrast NN N
, , N
in IN N
patients NNS N
with IN N
kidney NN N
disease NN N
, , N
time NN N
to TO N
discharge VB N
and CC N
total JJ N
cost NN N
of IN N
treatment NN N
were VBD N
similar JJ N
in IN N
both DT N
groups NNS N
. . N

CONCLUSION NNP N
When WRB N
applying VBG N
BNP NNP i
cut-off NN N
values NNS N
without IN N
adjustment NN N
for IN N
the DT N
presence NN N
of IN N
kidney NN N
disease NN N
, , N
the DT N
use NN N
of IN N
BNP NNP o
levels NNS o
does VBZ N
significantly RB N
improve VB N
the DT N
management NN N
of IN N
patients NNS N
without IN N
kidney NN N
disease NN N
, , N
but CC N
not RB N
of IN N
those DT N
with IN N
kidney JJ N
disease NN N
. . N
